The risk wasn’t limited to older adults. In fact, it was younger Americans who saw the most dramatic increases.
Younger adults saw shocking risk increases
For people normally considered decades away from dementia:
Ages 35–49 taking gabapentin had more than double the risk of dementia.
Their risk of MCI more than tripled.
Adults 50–64 saw similarly elevated risks.
Only those 18–34 showed no increased risk.
Researchers published their results in Regional Anesthesia & Pain Medicine and didn’t mince words: “Our results support the need for close monitoring of adult patients prescribed gabapentin to assess for potential cognitive decline.”
